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CHARACTERISTICS OF CHILDREN WITH MEDICAL COMPLEXITY 
EXPERIENCING MEDICATION ORDERING ERRORS AT HOSPITAL 
ADMISSION  
VINITA AKULA 
ABSTRACT 
 Medication errors make up a staggering portion of medical error in the United 
States. These medication errors are most likely to occur at transitions in care. Children 
with medical complexity (CMC) often rely on multiple medications to maintain their 
health, making accurate medication ordering of utmost importance to avoid exacerbating 
chronic conditions or unnecessary harm. Because of their increased medication usage, 
CMC have an increased risk of medication ordering error (MOE). To better inform the 
medication reconciliation process for CMC, we examine the prevalence, category, and 
risk factors of MOE at hospital admissions for this patient population.  
 A retrospective cohort analysis of 1,237 hospitalized CMC from two tertiary 
pediatric teaching hospitals with clinical care services for CMC was performed on data 
from November 1, 2015 to October 31, 2016. Pharmacists and advance nurse 
practitioners identified MOEs at admissions through medical record review, patient 
history at interview, and inpatient team discussions. Identified MOEs were classified as 
one of seventeen different categories, some of which include duplications, omissions, or 
incorrect frequency, dose, or route. Statistical analysis was performed using Fisher’s 
exact test, chi-squares, and generalized linear mix models to examine the relationships 
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between MOEs at admission and patient characteristics, such as ethnicity, number of 
chronic conditions, or number of medications taken at admission. 
 A total of 115 admission MOEs were identified in 73 hospitalized CMC. The two 
most common MOE types were wrong dose (41.7%) and omitted medication (33.9%). 
The median number of medications ordered at admission was 10 (IQR 6-14). 
Medications most commonly associated with an MOE were cholecalciferol (n=9) and 
baclofen (n=9). As for patient characteristics, the median age at admission was 5 years 
([Interquartile Range [IQR] 1-12). Of the total sample, 96.8% had a complex chronic 
condition and 72.8% were technology dependent. Children who are Black, require 
medical technology, or take more than 15 medications during hospitalization were found 
to have higher MOE rates. Multivariable analysis revealed the highest odds of MOE in 
children taking baclofen (Odds Ratio [OR] 2.6 [95% Confidence Interval {CI} 1.4-4.7]).  
 MOEs at admission are prevalent among hospitalized CMC. Further study on 
medication safety in CMC is needed to inform medication reconciliation processes and 
better prevent patient harm.   
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 1 
INTRODUCTION 
With its pluralistic delivery structure incorporating a large number of small 
providers, the American health care system magnifies the number of venues a given 
patient must visit to successfully navigate their coordinated care. Interacting with any 
amalgam of primary care physicians, specialists, nursing staff, pharmacists, emergency 
departments, home care agencies, diagnostic centers, acute care hospitals, and other 
caregivers, a patient’s coordinated care among multiple independent providers is complex 
and challenging (Bodenheimer, 2008). While the complexity of coordinated care can be 
mitigated for the typical patient, the challenges are exacerbated in patients with several 
chronic conditions. A typical Medicare beneficiary, between the years 2000-2002, would 
see a median of two primary care physicians and five specialist per year whereas patients 
with several chronic conditions would visit upwards of 16 physicians per year, in addition 
to accessing pharmaceutical, diagnostic, and related healthcare services (Pham, Schrag, 
O’Malley, Wu, & Bach, 2007). The coordination of patient medical information through 
all points of care is paramount to avoid wasteful duplication of medication, perilous 
polypharmacy, general mishandling of the administration of medication, and undue 
confusion about conflicting care plans (Bodenheimer, 2008). 
 Taming the complexity intrinsic to the coordination and management of health 
care requires multitudinous research initiatives in addition to the support of policy and 
political interest. Here, we focus on addressing discrepancies related to medication errors. 
Unintended medication discrepancies have been found in upwards of 67% of admitted 
patients (Tam et al., 2005). Analogous to the challenges of coordinating care in patients 
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with chronic conditions, these discrepancies are exacerbated by the additional complexity 
associated to their care. 
Medication Errors 
We first define the term medication error as the errors occurring in the process of 
ordering or administrating a given medication, irrespective of the presence of a potential 
for injury or whether an injury results. Under this definition, a medication error can arise 
at any stage of delivery such as during the pharmaceutical ordering, dispensing, and 
administration process (Bates, Boyle, Vliet, Schneider, & Leape, 1995). The Institute of 
Medicine of the National Academies reported in 2006 that medication errors are among 
the most common medical errors. They conservatively estimated that medication errors 
resulted in harming a minimum of 1.5 million people every year and that the incurred 
medical costs of treating drug-related injuries amount to $3.5 billion a year (Aspden, 
Wolcott, Bootman, Cronenwett, & others, 2007). In the more extreme cases, an estimated 
7,000 patient deaths have been attributed to medication errors throughout the United 
States. The prevalence of medication errors has been found to be consistent across 
different health care systems: hospitals in the United Kingdom report finding prescription 
errors in 1.5% of prescriptions, and administration errors occurring in as much as 8% of 
non-intravenous doses (Dean, Schachter, Vincent, & Barber, 2002; Ghaleb et al., 2006). 
As in other areas of patient safety, errors are more common than actual harms. 
While the majority of medication errors do not negatively impact the patient, a 
considerable portion manifest with negative consequences for the afflicted. This subset of 
medication errors are known as adverse drug events (ADEs) and we define them as 
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preventable injuries resulting from medical intervention related to a drug (Kaushal et al., 
2001; Kohn, Corrigan, & Donaldson, 2000). The occurrence of ADEs can, on average, 
prolong hospital stays by 1.7 to 4.6 days. Within an inpatient setting, ADEs account for a 
third of all hospital adverse events, afflicting approximately two million hospital stays 
per year (“Medication Errors | AHRQ Patient Safety Network,” 2017). The financial 
ramifications of ADEs upon contemporary health care institutions has been 
conservatively estimated at $5.6 million per hospital for a given year (Kohn et al., 2000). 
Fortunately, the majority of ADEs are preventable since they arise from incomplete 
prescription information, errors in the prescription or dispensing of drugs, or the 
overuse/underuse of medications, which comprise as many as 58% of all ADEs (Leape et 
al., 1995). At admission, 60-70% of medical histories contain at least one error (Tam et 
al., 2005). Furthermore, the problem propagates throughout a patient’s program of 
treatment, where occurrence of ADEs after discharge are primarily attributed to the 
failure to obtain an accurate and complete pre-admission medical history 
(Meguerditchian, Krotneva, Reidel, Huang, & Tamblyn, 2013; Pippins et al., 2008). In 
fact, related literature has modelled the rate of MOEs as a Poisson distribution and found 
evidence for increased rates of MOEs at the points of transition of care, often at 
admission (Kaushal et al., 2001). 
 
Medication Errors at Transitions in Care 
The periods of transition in care are of particular significance for MOEs. These 
transitions include admission, discharge, and transfer from services within the hospital. 
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Poor communication and inadvertent information loss at points of transition create an 
increased risk for error (Kripalani, Jackson, Schnipper, & Coleman, 2007; Kwan, Lo, 
Sampson, & Shojania, 2013; van Walraven et al., 2010). Unintentional changes to patient 
medication regimens, such as the above mentioned, are an active area of research (Bell et 
al., 2011; Kwan et al., 2013; Tam et al., 2005). More specifically, approximately half of 
the medication errors occurring within the hospital setting occur at admission or 
discharge (Sullivan, Gleason, Rooney, Groszek, & Barnard, 2005), from which an 
estimated 30% have the potential to result in patient harm (Vira, Colquhoun, & Etchells, 
2006).  
It is important to emphasize that differences between medications at preadmission 
and at discharge may be the result of deliberate alterations to a patient’s health care 
regimen as a result of the condition that led to hospitalizations. An example might be the 
withholding of antihypertensive medications in patients suffering of septic shock. In such 
a case, it is clear that the deliberate change in medication regimen was due to what led to 
hospitalization. We differentiate these occurrences from those discrepancies arising as the 
result of inaccurate or incomplete information of current medications and dosages. As 
previously discussed, an estimated 67% of patients are reported as having unintended 
discrepancies at hospital admission and the fact that these discrepancies remain through 
discharge is indicative of contemporary inefficiencies and shortcomings within the 
general healthcare system (Tam et al., 2005). Fortunately, the unintended discrepancies 
with the potential to cause patient harm tend to comprise the minority of occurrence. 
However reported statistics can vary within the 11-59% range (Tam et al., 2005) which is 
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a non-insignificant portion and thus necessitating investigation. To this end, medication 
reconciliation efforts are implemented to correct any undue discrepancies in a patient’s 
medication regimen. 
 
Medication Reconciliation 
We formally define medication reconciliation as the process of identifying and 
correcting unintended discrepancies of medication throughout the transition of care. This 
definition has been mandated by the World Health Organization and widely endorsed by 
the broader medical community (Joint Commission, n.d.; Kwan et al., 2013; Organization 
& others, 2008). This process is built upon the concept of the Best Possible Medication 
History (BPMH) which comprises a more comprehensive routine than that of primary 
medication history. The BPMH procedure requires two steps: 
1. Systematically obtaining the history of all medication (both prescribed or 
non-prescribed) by means of a structured patient interview 
2. Subsequent validation of the information provided in step 1 with at least 
one other reliable source 
Examples of reliable sources include patient medication lists, community pharmacies, 
government medication databases, or a primary care physician (Fernandes & Shojania, 
2012). 
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The minimum requirements of the medication reconciliation process necessitate the 
completion of the BPMH process and the subsequent correction of all identified 
unintended discrepancies. As explained above, these will manifest for a number of 
reasons: 
 
Figure 1. Overview of Medication Reconciliation in Acute Care. Adapted from  
Kwan et al., 2013. 
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1. Discrepancies arising from changes between the previous medication regimen 
and the proposed medication orders at admission 
2. Discrepancies arising through inpatient transfers 
3. Discrepancies arising during discharge to home or a health care facility 
The implementation of a more robust medication reconciliation processes necessitates a 
finer-resolution of sharing of patient information and interprofessional collaborations. 
Such a system must intelligently integrate the discharge summaries and prescriptions and, 
through all stages, provide medication counselling to patients as needed (Fernandes & 
Shojania, 2012). An example of such a system might have a physician, nurse, and 
pharmacist seamlessly integrated into an interoperable system to coordinate the 
management of a patient’s medication regimen at all points. The last decade has seen a 
number of initiative to bundle the process of medication reconciliation with other 
interventions in an effort to holistically improve the quality of transitions of care. Some 
of these bundled interventions in care include a coordination of subsequent appointments, 
patient counseling related to discharge care plans, and leveraging post-discharge 
communications (Jack, Chetty, Anthony, Greenwald, & Sanchez, 2009; Koehler et al., 
2009; Kripalani et al., 2012).   
Irrespective of the implementation of the medication reconciliation process, it is 
equally important to understand the patient population with a disproportional reliance 
upon this system. Since the medication reconciliation process predominately applies to 
those at greater risk of accumulating MOEs, we discuss the ramifications for these 
disproportionately affected populations. 
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Populations at Greater Risk for Medication Errors 
The populations disproportionally afflicted with higher rates of MOEs are the elder and 
pediatric populations. Here, we discuss the common and unique factors attributed to 
higher rates of MOEs in these two populations and then expand upon the association of 
MOEs within the sub-population of children with medical complexity. 
 
Elderly Populations 
 Elderly patients, aged 65+ years, are a vulnerable population. They have been 
reported as having a 2-5 fold increase in likelihood of hospital admission, incur hospital 
lengths of stay around 15% higher than national averages, represent upwards of a fifth of 
all visits to the emergency department, and as a result, tend to consume a disproportionate 
amount of acute health care resources (Aminzadeh & Dalziel, 2002; DeFrances & Hall, 
2007; Koehler et al., 2009). In the context of medication errors, this population is at a 
higher risk of ADEs than the general population given that they are prone to 
polypharmacy and multi-morbidity (Metsälä & Vaherkoski, 2014). More specifically, a 
number of critical factors pertaining to medication safety have been associated with elder 
populations including drug interactions from polypharmacy, undesirable side effects from 
prescribed medications, recognizant of the combinatorial use of medicines from different 
sources and the patient’s medical state. Further complications arise from a paradoxical 
over-prescription and under-compliance to adhere to medication administration. These 
respectively arise from a slowed metabolism attributed to the aging process and the 
underuse of prescribed medication as the result of a caregiver’s uncertainty about the 
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proper medication therapy for various pharmaceuticals (Jyrkkä, Enlund, Korhonen, 
Sulkava, & Hartikainen, 2009; Lin, Liao, Cheng, Wang, & Hsueh, 2008; Metsälä & 
Vaherkoski, 2014).  
 Further complexities of the health care of elder populations, which produce 
barriers to the adequate documentation of geriatric patient medical history, include 
cognitive impairment, poor social support, and poor pharmaceutical knowledge 
(Wakefield et al., 1999). The inevitability of MOEs arising in these populations have 
given rise to startling statistics wherein among polymedicated patients, the complete 
agreement between a patient’s adherence to their medication list occurs in only 5% of the 
elder patient population (Steurbaut et al., 2010). Evidently a medication reconciliation 
program promises to have important ramifications for the MOE high risk elder 
populations. 
 
Pediatric Populations 
 The vast majority of studies related to medication errors and medication 
reconciliation have focused on adult populations. The literature related to the incidence of 
medication errors in pediatrics is sparse despite reports of a higher prevalence of these 
errors (Ghaleb et al., 2006). A study in the United Kingdom on pharmacist intervention in 
drug treatment found higher intervention rates in pediatric wards than geriatric, surgical, 
or medical wards (Barber, Batty, & Ridout, 1997). Furthermore, not only are the rates of 
MOEs greater within pediatric populations, but those potentially harmful medication 
errors which necessitate rapid intervention were found to be three times more common in 
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pediatric populations when compared to adults. This strongly suggests the epidemiologic 
characteristics of medication errors differ between adult and pediatric populations 
(Kaushal et al., 2001).  
 During adolescent development, the body is subject to wide variations in mass. 
Pediatrics therefore pose unique risks when determining appropriate medication dosage 
to account for these broad variations. Generally, the patient’s weight, height, age, body 
surface area, and personal clinical conditions must be taken into account to arrive at an 
appropriate dosage determination. The breadth of factors to consider and their intrinsic 
susceptibility to fluctuate in short time-periods relative to adults inevitably increases the 
likelihood of errors (most notably, medication dosage errors) (Ghaleb et al., 2006; Wong, 
Ghaleb, Franklin, & Barber, 2004). In particular, neonates are at the highest risk given 
that their internal reserves are much more limited than that of older children or adults, 
resulting in an increased inability to buffer medication dosage errors (Kaushal et al., 
2001). 
 Further exacerbating these challenges, young children are not equipped with the 
communication skills or experiential knowledge to advise clinicians about susceptible 
medication administration errors or the anticipated adverse effects they may experience 
downstream of their treatment.  
 The comparison of the population of hospitalized children with medication errors 
against those hospitalized children without known medication errors revealed a 2-18 time 
increase in mortality rate, a 2-20 time increase in cost of care, and up to six times longer 
length of stay (Miller, Elixhauser, & Zhan, 2003).  
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 Following decades of research into quality improvement initiatives, the 
occurrence of medication errors persist in hospitalized children populations and concerted 
efforts are required to resolve these challenges (Kaushal et al., 2001). While these 
characteristics manifest throughout the general pediatric population, a subset of this 
population is further disproportionately afflicted by high rates of MOEs: children with 
medical complexity. 
 
Children with Medical Complexity 
Children with medical complexity (CMC) are a subset of the pediatric population 
that are especially vulnerable to medication errors (Berry et al., 2011). Similar to elderly 
populations, the presence of multiple chronic conditions and polypharmacy increase the 
risk of ADEs in CMCs. A study examining the prevalence of children with special health 
care needs estimated 13% to 18% of youth in the United States have a chronic health 
conditions that requires increased use of health services compared to their healthy 
counterparts (van Dyck, Kogan, McPherson, Weissman, & Newacheck, 2004). An 
increasing number of these children have a complicated, fragile chronic disease or 
multiple chronic conditions that deem these patients to be medically complex (Gordon et 
al., 2007). 
Broadly, CMC is defined as having a congenital or acquired multisystem disease, 
severe neurologic impairment, and/or technology dependence for daily activities (Cohen 
et al., 2011). A definitional framework for CMC was created by Cohen et al. in an 
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attempt to standardize the definition across literature. This definition includes four broad 
domains to characterize childhood chronic conditions (Figure 2): 
1. Needs: Health care service needs identified by the family, such as medical 
care, educational needs, or specialized therapy. The responsibility falls on the 
family to provide the time, care coordination, and financial means to meet the 
child’s increased needs. 
2. Chronic conditions: CMCs have one or more diagnosed or unknown chronic 
clinical conditions that are associated with high morbidity and mortality rates. 
These conditions are expected to be lifelong, although some may improve 
with time and attentive care. 
3. Functional limitations: The ability of child to use key dimensions of body 
structure and function, perform daily activities, and participate in communal 
life determine how well they can function in an everyday setting. CMC 
experience severe limitations that may necessitate technology, such as a 
feeding tube or respiratory machine. These functional limitations can vary in 
type and severity over the child’s life.  
4. Health care use: CMCs generally have high health care resource utilization. 
This can include lengthy or frequent hospital visits, multiple procedures, or 
multiple specialty care services and providers. Health care use can also vary 
over time.  
The combination of specific manifestations of these four domains conceptually 
encompass the features of CMC. This growing population of children with medical 
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complexity requires high-intensity, coordinated care at all levels, from primary, 
community, and multiple-specialty providers (Cohen et al., 2011). Increased health care 
usage and hospitalizations put CMC at a greater risk for inpatient medical errors due to 
admitting clinicians being unfamiliar with the complex medication history when ordering 
medications (Coffey et al., 2009; Stone, Boehme, Mundorff, Maloney, & Srivastava, 
2010). More information on medication errors for CMC is needed to better inform how to 
catch and prevent errors from occurring (Feudtner, Dai, Hexem, Luan, & Metjian, 2012; 
Maaskant et al., 2015).  
 In compiling information related to MOEs in CMC and correcting them as soon 
as they are discovered, medical institutions can improve the procedures and ultimately, 
offer a better standard of care to these patient populations exhibiting a high degree of 
medical complexity. These procedures should be implemented in a way which minimizes 
the time between the detection of an MOE and the subsequent correction so as to avoid 
the potential harm of the MOE, moving in the direction of “real-time” systems. 
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Figure 2. Framework for the definition of children with medical complexity. 
Adapted from Cohen et al., 2011. 
 
Necessity of Real-Time System to Resolve Medication Ordering Errors 
The shortcomings of contemporary medical systems with respect to the inevitable 
increase of MOEs at various stages of a patient’s trajectory through their coordinated care 
necessitate new approaches to resolve these discrepancies. Drawing inspiration from 
related challenges in medication management, the use of advances in technology have 
emerged as a promising solution to address poor medication adherence (Granger & 
Bosworth, 2011). Analogous to the high resource intensity involved with the coordinated 
management of medication orderings, existing evidence-based adherence interventions 
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are plagued by high resource demand, lack specificity regarding delivery and medication 
content, and are impractical for everyday clinical practice settings (Nieuwlaat et al., 
2008). A number of technological solutions have been proposed to improve medication 
adherence and alleviate the burden imposed upon contemporary medical systems 
(Granger & Bosworth, 2011; Hayakawa et al., 2013; Vervloet et al., 2011).  
 The ability to monitor a patient’s medication regimen is critical for the 
identification of MOEs to catch any discrepancies. In fact, the sooner these MOEs are 
caught, the sooner a corrective action can be applied which is critical in order to avoid 
undue downstream patient injury. It is not inconceivable that these corrections might 
occur in time-frames so rapid that the original discrepancy would not be perceivable in 
the general clinical operations, effectively resolving the contemporary challenges of 
MOEs in the clinical setting. To move towards this goal, we must consider adopting 
clinical procedures and techno-centric solutions that operate in real- or near real-time 
conditions. More specifically, whenever information related to a patient’s medication 
history becomes available, that information is immediately considered within the context 
of the patient’s current and past medical history to resolve any potential discrepancies. 
 To this end, we implemented an experimental study design which identifies 
MOEs soon as they are caught and thereby operates within near real-time conditions. We 
propose that similar studies follow suit to the study design proposed herein in alignment 
with the effort to shift towards the reduction of the timeframe between the identification 
and subsequent rectification of MOEs. We recognize that while such a shift would 
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minimally benefit the wider patient population, we emphasize that its consequences for 
patient populations at risk of disproportionally high rates of MOEs would be substantial.  
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METHODS 
 
This section provides a high-level overview of the setting and study design 
utilized in this work. The patient population, study participants, and their characteristics 
are first described, followed by definitions of the main measured outcome, and concludes 
with an overview of the statistical analyses employed. 
 
Study Design, Setting, and Participants 
This is a retrospective analysis of data collected from a multi-center study of 
medication ordering errors during hospitalization pertaining to CMC, leveraging data 
acquired between November 1st, 2015 and October 31st, 2016 at two acute-care 
children’s hospitals. Both settings defined CMC as children having lifelong, multi-
systemic chronic conditions resulting in significant impairment of physical and/or 
cognitive functioning. These patients were each enrolled as part of a structural inpatient 
clinical program dedicated to CMC management and coordination. Those considered 
eligible for inclusion were hospitalized CMC admitted to a general pediatric hospitalist 
service staffed by pediatric residents and an attending physician. 
The longitudinal tracking of these medication ordering errors was accomplished 
by nurse practitioners and pharmacists at each location. Following an evaluation of the 
CMC’s admission history and physical examination, the pediatric residents used a 
computerized order entry system to order all medications at admission. Beyond this 
preliminary evaluation, and in an effort to comprehensively summarize all medications, 
the residents were also required to review all home medication in conjunction with 
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hospital nurses and family caregivers, where available. The respective institutional 
review boards of the Boston Children’s Hospital and the Monroe Carell, Jr., Children’s 
Hospital at Vanderbilt approved this study design and the data collection procedures by 
means of a waiver of informed consent. 
 
Main Measured Outcome: Medication Ordering Error 
We used the number of medication ordering errors (MOE) at admission as the 
main measured outcome in this work. More specifically, the MOEs that required the 
revision of the order at the time of admission to mitigate potential or an adverse 
medication event and/or patient harm were compiled. Examples of such MOEs include: 
1. Incorrect medication dosage 
2. Incorrect medication prescription 
3. Incorrect frequency of delivery 
4. Incorrect timing of delivery 
5. Omission of medications 
6. Duplication of medications 
All MOES at the time of admission were prospectively identified by members of the 
clinically integrated nurse practitioners and/or pharmacists along with the admitting 
hospital teams. At the time of admission, the clinicians proactively compared all 
medications ordered by pediatric residents. Where possible, the clinicians further 
compared these orders with the medical history of orders as documented by the in-patient 
floor nursing staff and the patient family. Furthermore, the patient’s and families were 
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interviewed while consulting the electronic medical record to evaluate outpatient clinical 
notes, prior prescriptions, the summaries of prior hospital discharges, and any 
documentation amenable to the verification of medication orderings. All MOEs identified 
following the study protocol were corrected immediately following their detection and 
subsequently documented in a HIPAA-compliant database. 
We assessed the number and type (i.e., therapeutic class and group) of 
medications administered for each patient during hospitalization. Medication 
classification was based on the National Drug Code (NDC) reported in the 2013 version 
of the Red BookTM (Truven Health Analytics, Ann Arbor, MI). Using the NDC, we 
applied the American Hospital Formulary System (AHFS) Pharmacologic-Therapeutic 
Classification to each medication, classifying it into one of 24 mutually exclusive 
therapeutic groups, and then into one of 223 mutually exclusive medication classes. As 
an example, the medication phenobarbital resides in the central nervous system 
therapeutic group and the anti-epileptic medication class. 
 
 
Patient Characteristics 
The Pediatric Health Information System (PHIS) for each respective hospital was 
used to assess the clinical characteristics and patient demographics for correlations with 
MOE following the acute-care hospitalization of CMC. More specifically, demographic 
characteristics included age, gender, race/ethnicity (Hispanic, non-Hispanic Black, non-
Hispanic White, other), age at admission (in years), and insurance status (public, private, 
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other). All patient data was de-identified locally and encrypted in order to pool the data 
and merge with PHIS. 
Each CMC’s clinical characteristics were assessed following the International 
Classification of Disease (9th Revision), Clinical Modification (ICD-9-CM codes) for 
complex chronic conditions (CCC) (Feudtner, Feinstein, Zhong, Hall, & Dai, 2014). Here 
we consider CCC’s diagnosis groupings as defined in Cohen et al.: anticipated to last for 
more than a year and involve either a single organ system (with a severely necessitating 
specialty pediatric care and hospitalization), or multiple organ systems (Cohen et al., 
2011). These clinical characteristics were summarized by both the type and number and 
included the assistance of medical technology. For example, hospitalized children 
assisted with medical technology were identified with ICD-9-CM codes indicating the 
use of a medical device to maintain basic body functions necessary for sustaining life 
(e.g. a tracheostomy tube for breathing) or to manage and treat a chronic illness (e.g., 
ventricular shunt to treat hydrocephalus) (Feudtner et al., 2005; Palfrey et al., 1991). In 
total, the PHIS contains upwards of 41 ICD-9-CM diagnostic codes per hospital 
discharge record. 
  
Statistical Analysis 
We define MOEs at admission as the occurrence of one or more MOE per 
admission (³1 MOE/admission). We selected this definition for the measurement of 
MOEs for two reasons: 
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1. The majority of CMCs within the structured clinical program are reliant 
upon multiple medications and thereby are susceptible to a high 
prevalence of multiple MOEs 
2. The personnel operating these structured clinical programs consider MOE-
free admissions as the principal outcome in the pursuit of providing a high 
standard of care at admission to CMC 
This work used bivariate analysis to compare the rates of MOE within selected 
subgroups across various patient clinical and demographic characteristics. We applied 
Fisher’s exact test to determine whether a statistically significant difference between 
groups existed, under the null hypothesis (!": no statistical difference between the 
subgroups examined). Under these test conditions, we determined statistical significance 
at the $ = 0.05 level. 
Furthermore, we assessed the rates of MOEs within 1-unit epochs, here defined as 
the span of one year. These assessments considered variables such as the number of, 
class, and group of medications in addition to patient age. The results of these findings 
were further categorized for subsequent downstream analysis. 
Finally, we applied multivariate analysis wherein we developed a logistic 
regression model derived from both the clinical and demographic characteristics 
identified from the analyses listed above. All analyses were performed using the STATA 
statistical programming framework. 
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RESULTS 
This study included 1,237 hospitalizations in the analysis. This work anticipates a 
commensurate increase in available MOE data throughout the duration of this ongoing 
study. Our primary reported measure of outcomes uses the median and interquartile range 
(IQR) to capture the resulting distribution in favor of the mean and standard deviation to 
account for outliers and skewness in the resulting distribution. We cannot assume that 
MOEs follow a normal distribution and thereby report findings in such a way that enables 
a more flexible assessment of the underlying distribution of our findings. 
 
Study Population 
  The median length of stay for all CMC was 3 days and an IQR of 2-7. The 
median age at admission was 5 years and IQR of 1-12. The majority of hospitalizations 
were for non-Hispanic children (79.9%) and for children using public insurance (51.8%). 
Most children (97.0%) had a CCC and, with a median number of CCCs being 2 with IQR 
of 2-3. The most common CCCs were gastrointestinal (68.1%), neuromuscular (67.9%), 
and congenital/genetic (31.8%). We note that since a given patient can have numerous 
CCCs, the proportion of CCCs across the patient population can surpass 100% and we 
thus observe an over-representation in certain CCCs. When evaluating assistance with 
medical technology, we found that 73% of children utilized this form of assistance. 
Finally, we report the median and IQR of the number of medications, drug classes, and 
therapeutic groups ordered during hospitalization as 10 (IQR 6-14), 4 (IQR 3-5), and 6 
(IQR 4-9), respectively. For each of these, we emphasize the most common medications, 
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therapeutic classes, and medication groups. The five most common medications were 
levetiracetam, acetaminophen, omeprazole, sodium chloride, and ranitidine; the three 
most common medication classes were fluid nutrients and gastrointestinal agents, central 
nervous system and autonomic agents, and anti-infective agents; and the three most 
common therapeutic categories were gastrointestinal agents, anticonvulsant, sand 
analgesics/antipyretics. Table 1 details the examined characteristics of the patient 
population.  
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Table 1. Characteristics of Hospitalized Children with Medical Complexity in the 
Study Cohort. P-value showing if distribution between hospitals differ significantly at 
p<0.001.   
 
Characteristic Total Hospital A Hospital B P-value N % N % N % 
Demographic Characteristics 
Age at Admission in Years 
  <1 202 16.3% 91 45.0% 111 55.0% <0.001 
  1-5 460 37.2% 171 37.2% 289 62.8% 
  6-12 280 22.6% 100 35.7% 180 64.3% 
  ≥13 295 23.8% 78 26.4% 217 73.6% 
Gender 
  Female 564 45.6% 231 41.0% 333 59.0% <0.001 
Race 
  White 707 61.0% 330 46.7% 377 53.3% <0.001 
  Black 130 11.2% 75 57.7% 55 42.3% 
  Asian 31 2.7% 7 22.6% 24 77.4% 
  American Indian 7 0.6% 1 14.3% 6 85.7% 
  Other 284 24.5% 0 0.0% 284 100.0% 
Ethnicity 
  Hispanic or Latino 151 12.2% 151 100.0% 0 0.0% <0.001 
  Not Hispanic or       
  Latino 988 79.9% 575 58.2% 413 41.8% 
  Unknown 98 7.9% 71 72.4% 27 27.6% 
Payor 
  Private 437 35.3% 157 35.7% 280 35.1% <0.001 
  Medicaid 641 51.8% 283 64.3% 358 44.9% 
  Other 159 12.9% 0 0.0% 159 19.9% 
Clinical Characteristics 
Disposition 
  Home/Self Care 1124 90.9% 419 37.3% 705 62.7% <0.001 
  Other 112 9.1% 20 17.9% 92 82.1% 
Number of Complex Chronic Conditions 
  0-1 251 20.3% 72 28.7% 179 71.3% <0.001 
  2 460 37.2% 141 30.7% 319 69.3% 
  ≥3 526 42.5% 227 43.2% 299 56.8% 
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Table 1 (Continued). Characteristics of Hospitalized Children with Medical 
Complexity in the Study Cohort. 
 
 
 
Medication Order Errors at Admission   
 
At admission, we found 6.0% (n=73) of hospitalizations were associated with at 
least MOE; a total of 115 admission MOEs were identified. Of these, wrong dose, 
omitted mediation, and wrong frequency made up a majority of these MOEs with 41.7%, 
33.9%, and 7.8% respectively. Figure 3 displays the total breakdown of the types of 
MOE. The most common medications associated with MOEs were all chronic 
medications used by the children at home prior to admission. These included 
cholecalciferol (n=9), baclofen (n=9), clobazam (n=6) levothyroxine (n=5), 
glycopyrrolate (n=5), and ranitidine (n=5), diazepam (n=5), 
Number of Medications 
  0-14 964 77.9% 314 32.6% 650 67.4% <0.001 
  ≥15 273 22.1% 126 46.2% 147 53.8% 
Number of Drug Classes 
  0-3 459 37.1% 156 34.0% 303 66.0% 0.4 
  ≥4 778 62.9% 284 36.5% 494 63.5% 
Number of Therapeutic Categories 
  0-6 630 50.9% 210 33.3% 420 66.7% 0.09 
  ≥7 607 49.1% 230 37.9% 377 62.1% 
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Figure 3. Types of Medication Order Errors at Admission for Hospitalized Children 
with Medical Complexity 
 
 
Bivariable Analysis of Demographic Characteristics and Medication Order 
Errors at Admission 
 In this bivariable analysis, we compared the admission MOE with various 
demographic characteristics to determine whether a significant association existed. When 
first comparing with race/ethnicity, we found that the Non-Hispanic Black race was 
significantly associated with admission MOE: the rates of MOE for the Non-Hispanic 
Black children vs. other races were 10.1% vs. 5.5%, respectively (p = 0.05). Bivariate 
analysis was also performed to determine statistical associations for MOEs based on 
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gender, insurance models, and age. Across each of these variables, we determined 
differences in MOEs, but none were statistically significant. More specifically, higher rates 
of MOE were observed in males vs. females (6.8% vs. 4.8%, p=0.13), public vs. private 
insurance (6.9% vs. 5.0%, p=0.32), and older vs. younger age (e.g., 7.5% for age 13+ years 
vs. 3.0% for infants, p=0.11). These findings were not statistically significant with a p-
value greater than 0.1 in all of these cases. 
 
Bivariable Analysis of Clinical Characteristics and Medication Order Errors 
at Admission.  
We expanded the bivariable analysis to examine the number, class, and group of 
medications administered for statistically significant association with admission MOE. 
We noted that rates of MOE varied the most between hospitalizations of children using 
≥15 vs. 0-14 medications (8.4% vs. 5.2%, p = 0.05); ≥7 vs. 0-6 medication classes (7.7% 
vs. 4.1%, p = 0.007); and ≥4 vs. 0-3 medication groups (6.9% vs. 4.1%, p = 0.05). A finer 
examination into specific medications found that MOE rates at admission varied 
significantly for hospitalizations in those using vs. not using skeletal muscle relaxants 
(37.2% vs. 20.8%, p < 0.001) and that among these relaxants, admission MOE rates were 
higher with use vs. not use of baclofen (33.3% vs. 16.5%, p < 0.001).   
Furthering our bivariate analysis, we considered assistance with medical 
technology and in cases of CCCs. In the former case, we found an association with a 
higher rate of admission MOE. The rates of MOE for children using vs. not using 
technology were 7.0% vs. 3.0%, respectively (p<0.01). In the latter, it was found that 
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three or more chronic conditions was associated with an increased likelihood of an MOE 
at admission [OR 2.64 (CI 95% 1.2-5.7)]. Finally, only congenital or genetic defects were 
found to have a statistically significant association with MOE using a bivariable analysis 
(7.9%, p<0.05). The results of these bivariable analyses of MOE and patient 
characteristics are detailed in Table 2.  
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Table 2. Bivariable Analysis of Medication Order Error Rate and Patients’ 
Characteristics. 
 
Characteristic 
Medication Order 
Error at Admission 
Odds Ratio (95% 
CI) of Medication 
Order Error 
P-value 
N % 
Age 
  <1 6 3.0% REF  
  1-5 24 5.2% 1.8 (0.72-4.47) 0.21 
  6-12 21 7.5% 2.65 (1.05-6.69) <0.05 
  ≥13 22 7.5% 2.63 (1.05-6.61) <0.05 
Gender 
  Male 46 6.8% REF  
  Female 27 4.8% 0.69 (0.42-1.12) 0.13 
Race 
  White 41 5.8% REF  
  Black 12 9.2% 1.65 (0.84-3.24) 0.14 
  Asian 2 6.5% 1.12 (0.26-4.86) 0.88 
  Other 15 5.3% 0.91 (0.49-1.66) 0.75 
Ethnicity 
  Hispanic or Latino 9 6.0% REF  
  Not Hispanic or Latino 60 6.1% 1.02 (0.5-2.1) 0.96 
  Unknown 4 4.1% 0.67 (0.2-2.24) 0.52 
Payor 
  Private 22 5.0% REF  
  Medicaid 44 6.9% 1.39 (0.82-2.35) 0.22 
  Other 7 4.4% 0.87 (0.36-2.07) 0.75 
Disposition 
  Home/Self Care 64 5.7% REF  
  Other 8 7.1% 1.27 (0.59-2.73) 0.53 
Number of Complex Chronic Conditions 
  0-1 8 3.2% REF  
  2 23 5.0% 1.6 (0.7-3.63) 0.26 
  ≥3 42 8.0% 2.64 (1.22-5.7) <0.05 
Number of Medications 
  0-14 50 5.2% REF  
  ≥15 23 8.4% 1.68 (1.01-2.81) <0.05 
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Table 2 (Continued). Bivariable Analysis of Medication Order Error Rate and 
Patients’ Characteristics. 
 
 
 
 
Multivariable Analysis  
Expanding this work to consider a more complex model, we performed a 
multivariable analysis over the set of all patient demographic characteristics including 
age, race/ethnicity, and insurance payor models. We determined that none of these 
patients’ demographic characteristics were associated with a probability of admission 
MOE (p > 0.1 for all test conditions). Finally, we repeated the same in relation to clinical 
characteristics and found that the number of CCC and assistance with medical technology 
in addition to the number of medications, medication groups, and medication classes 
were not associated with a probability of admission MOE (p > 0.1 for all test conditions). 
However, higher odds of admission MOE were observed in those using a skeletal muscle 
relaxant (37.2% vs. 20.8%, p<0.001) and within that medication group, baclofen was 
associated with a higher odds of admission MOE [OR 2.6 (95%CI 1.5-4.8)]. These 
findings are summarized in Figure 4.
Number of Drug Classes 
  0-3 19 4.1% REF  
  ≥4 54 6.9% 1.73 (1.01-2.95) <0.05 
Number of Therapeutic Categories 
  0-6 26 4.1% REF  
  ≥7 47 7.7% 1.95 (1.19-3.19) <0.05 
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Figure 4. Multivariable Analysis of Medication Order Errors at Admission for Hospitalized Children with Medical 
Complexity 
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DISCUSSION 
 
This study corroborates literature evidence that hospitalized CMC are prescribed a 
large number of medications, with over 5% of CMC hospitalizations containing at least 
one MOE at the time of admission. Across all categories of type of MOE, wrong dosages 
and omitted medications were found to be the most common. Additionally, all MOEs 
were determined to occur in home medications used by CMC that should be continued in 
the event of hospitalization. These findings are in line with the inherent difficulty related 
to prescribing the correct medication dosage to children due to their intrinsic 
susceptibility to fluctuate in height and weight during short time-periods relative to 
adults, inevitably increasing the likelihood of errors. The dosing errors can occur at any 
point in the medication ordering process (patient history recording, prescription, 
preparation, dispensing, or administration of the medication) (Lesar, Mitchell, & Sommo, 
2006). A rigorous evaluation of the prevalence of dosage errors in the general pediatric 
population and those in the CMC population would be required to determine whether the 
occurrence of wrong dosage MOEs is disproportionately elevated in CMCs or 
consistently prevalent among all children. A similar analysis could be performed to 
further investigate the prevalence of omitted medications, however such a study must 
control for number of medications to ensure a fair comparison. 
 When investigating associations between variables through bivariate analysis, this 
work found MOEs occurring more frequently in patients with a higher vs. lower number 
of medications, as expected; the binary split point of 14 vs. 15+ medications indicated the 
greatest MOE rate at admission. There were also higher frequencies associated to larger 
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number of drug classes as well as therapeutic categories. Across races, Black patients, 
when compared to other races, and those using medical technology were found to have 
higher rates of MOEs. Expanding this analysis to a multivariate analysis to investigate the 
rates of MOEs across drug types, we observed higher rates of MOEs associated to the use 
of skeletal muscle relaxants, namely baclofen. 
 The results of this study compare in many ways to existing literature with respect 
to the most common MOEs. Our finding that dosing errors as the most common type of 
MOE at admission is in agreement with prior work (Al-Jeraisy, Alanazi, & Abolfotouh, 
2011; Ghaleb et al., 2006; Kaushal et al., 2001). The consistency of these findings is 
notable given the differences in the comparison populations. The majority of prior work 
has focused on the quality of ordering and administration of short-term medications when 
treating acute illnesses in previously-healthy children (Al-Jeraisy et al., 2011; Ghaleb et 
al., 2006; Kaushal et al., 2001) in comparison to the current population of CMC. These 
findings suggest that dosage error MOEs may be common among all pediatric 
populations, however a dedicated study (as previously suggested) is required to draw 
such a conclusion. 
 Our findings also contrast prior studies from the observation that the omission 
MOEs of home medications at admission was relatively common among CMC; the 
medication should have been continued throughout hospitalization (Al-Jeraisy et al., 
2011; Ghaleb et al., 2006; Kaushal et al., 2001). Interestingly, this observation 
corroborates the work of Stone et al. (2010) wherein home medication omissions were 
among the most common MOE identified during the medication reconciliation process of 
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CMC at admission (Stone et al., 2010). The home medication omissions we observed in 
this study are cause for alarm given that, irrespective of the implementation of the 
standard medication reconciliation procedures upon admission, a considerable number 
were missed by the admitting pediatric resident and nursing teams. 
 This work is principally motivated by the desire to eliminate undue risk to 
hospitalized CMC whose precarious medical conditions are threatened by the 
disproportionately high rate of MOEs. The identification and subsequent correction of 
MOEs at admission of the hospitalized CMCs is paramount to avoid the risk of 
exacerbation of chronic condition during their participation in this study. For example, 
the omission of the continued administration of the home medication enteral baclofen for 
the treatment of chronic muscle spasticity could result in acute, life-threatening 
withdrawal (Alvis & Sobey, 2017). We emphasize the risks associated to baclofen in 
particular given that it was among the predominantly omitted medications observed in 
this work. 
 Likewise, the omission of two other medications investigated in this work, 
clobazam and glycopyrrolate, might have respectively led to increased seizures and 
sialorrhea (with possible aspiration) (Allen et al., 1983; Bachrach, Walter, & Trzcinski, 
1998). Anecdotally, from observed clinical experience, these home medications are 
disregarded or overlooked by the admitting hospital staff when the cause for 
hospitalization is unrelated to these home medications. Additionally, it has been observed 
that a number of admitting clinicians mistakenly perceive certain home medications (such 
as baclofen) as non-essential for continued administration throughout hospitalization. 
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These observations align with similar issues from other at-risk populations, namely, 
hospitalized elderly individuals with polypharmacy (Cornish et al., 2005; Karnon, 
Campbell, & Czoski-Murray, 2009; Lewis et al., 2009; Vira et al., 2006). While these 
observations are a cause for concern, one solution might be found in adapting the 
education and training of admitting staff for recognizance of the rate of MOEs among 
CMCs at admission. Certainly, further exploration is needed to investigate these 
perceptions. 
 The necessity to adopt techno-centric innovations or practices operating in near 
real-time is particularly critical following our findings of increased MOE rates at 
admission for CMC requiring 15+ medications. A recent study reported an average of 90 
minutes to complete the medication reconciliation upon admission of CMC with an 
average of 5 home medications (Meguerditchian et al., 2013; Stone et al., 2010). The 
effort involved in the process of thoroughly navigating and scrutinizing medication 
information from disparate sources such as pharmacy records, outpatient clinical notes, 
family members, and prior discharge notes is considerable. Studies within the 
hospitalized adult population found the process subject to high variation wherein the 
quality of the medication reconciliation process was largely affect by human factors 
(Almanasreh, Moles, & Chen, 2016). Variability in the knowledge and experience of 
interfacing with medication sources, in addition to the reviewer’s interest, energy, and 
attention contributed to variations in the quality of the resulting medication reconciliation 
process (van Sluisveld, Zegers, Natsch, & Wollersheim, 2012). Given the lack of prior 
work, far less is known about those factors mediating the reconciliation process for 
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hospitalized children and whether the human factors afflicting the adult population are 
common within pediatric populations. One study found that pediatric residents 
experiencing burn out and negative patient care attitudes/behaviors increase the 
likelihood of producing medication errors (Baer et al., 2017). Evidently, further 
investigations into the medication reconciliation process at admission for CMC are 
required. The facilitation of this laborious process by leveraging advances in technology 
to summarize and highlight potential discrepancies as they are entered could herald an 
age void of MOEs, where the reconciliation process is automatically carried out through 
the intelligent sharing of data across the disparate medication information sources. 
This study is limited in a number of ways. Foremost, the measured MOEs at 
admission are likely under-estimated given that they were counted by pharmacists and 
nurses conducting the prospective clinical work for hospitalized CMC. It is therefore 
difficult to appraise the true prevalence of MOEs across all tested conditions. 
Furthermore, while all medication orders for CMC were examined for error, they were 
not all appraised within standardized time scales. In particular, during the absences of 
study clinicians to assess MOEs (i.e., holidays), these error appraisals were considerably 
delayed with respect to others. To confirm the presence of a given MOE and to ensure a 
greater level of detection, complementary methods such as retrospective chart review and 
the use of electronic health record medication error trigger tool (as previously alluded to) 
could have been leveraged in support of the prospective review of charts. Finally, we 
anticipate the generalizability of the study findings to be best suited to pediatric teaching 
hospitals with clinical care services for CMC. We propose further study for admitted 
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CMC in non-teaching and community hospitals, particularly those who do not have 
specialty structured programs for CMC. 
  
 38 
REFERENCES 
 
Al-Jeraisy, M. I., Alanazi, M. Q., & Abolfotouh, M. A. (2011). Medication prescribing 
errors in a pediatric inpatient tertiary care setting in Saudi Arabia. BMC Research 
Notes, 4(1), 294. https://doi.org/10.1186/1756-0500-4-294 
Allen, J. W., Oxley, J., Robertson, M. M., Trimble, M. R., Richens, A., & Jawad, S. S. 
(1983). Clobazam as adjunctive treatment in refractory epilepsy. British Medical 
Journal (Clinical Research Ed.), 286(6373), 1246–1247. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/6404410 
Almanasreh, E., Moles, R., & Chen, T. F. (2016). The medication reconciliation process 
and classification of discrepancies: a systematic review. British Journal of Clinical 
Pharmacology, 82(3), 645–658. https://doi.org/10.1111/bcp.13017 
Alvis, B. D., & Sobey, C. M. (2017). Oral Baclofen Withdrawal Resulting in Progressive 
Weakness and Sedation Requiring Intensive Care Admission. The Neurohospitalist, 
7(1), 39–40. https://doi.org/10.1177/1941874416637404 
Aminzadeh, F., & Dalziel, W. B. (2002). Older adults in the emergency department: a 
systematic review of patterns of use, adverse outcomes, and effectiveness of 
interventions. Annals of Emergency Medicine, 39(3), 238–247. 
https://doi.org/10.1067/MEM.2002.121523 
Aspden, P., Wolcott, J. A., Bootman, J. L., Cronenwett, L. R., & others. (2007). 
Preventing medication errors. National Academies Press Washington, DC. 
Bachrach, S. J., Walter, R. S., & Trzcinski, K. (1998). Use of Glycopyrrolate and Other 
Anticholinergic Medications for Sialorrhea in Children with Cerebral Palsy. Clinical 
Pediatrics, 37(8), 485–490. https://doi.org/10.1177/000992289803700805 
Baer, T. E., Feraco, A. M., Tuysuzoglu Sagalowsky, S., Williams, D., Litman, H. J., & 
Vinci, R. J. (2017). Pediatric Resident Burnout and Attitudes Toward Patients. 
Pediatrics, 139(3), e20162163. https://doi.org/10.1542/peds.2016-2163 
 
 39 
Barber, N. D., Batty, R., & Ridout, D. A. (1997). Predicting the rate of physician-
accepted interventions by hospital pharmacists in the United Kingdom. American 
Journal of Health-System Pharmacy : AJHP : Official Journal of the American 
Society of Health-System Pharmacists, 54(4), 397–405. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9043562 
Bates, D. W., Boyle, D. L., Vliet, M. B. Vander, Schneider, J., & Leape, L. (1995). 
Relationship between medication errors and adverse drug events. Journal of General 
Internal Medicine, 10(4), 199–205. https://doi.org/10.1007/BF02600255 
Bell, C. M., Brener, S. S., Gunraj, N., Huo, C., Bierman, A. S., Scales, D. C., … Urbach, 
D. R. (2011). Association of ICU or Hospital Admission With Unintentional 
Discontinuation of Medications for Chronic Diseases. JAMA, 306(8), 840–847. 
https://doi.org/10.1001/jama.2011.1206 
Berry, J. G., Agrawal, R., Kuo, D. Z., Cohen, E., Risko, W., Hall, M., … Srivastava, R. 
(2011). Characteristics of hospitalizations for patients who use a structured clinical 
care program for children with medical complexity. The Journal of Pediatrics, 
159(2), 284–290. https://doi.org/10.1016/j.jpeds.2011.02.002 
Bodenheimer, T. (2008). Coordinating Care — A Perilous Journey through the Health 
Care System. New England Journal of Medicine, 358(10), 1064–1071. 
https://doi.org/10.1056/NEJMhpr0706165 
Coffey, M., Mack, L., Streitenberger, K., Bishara, T., De Faveri, L., & Matlow, A. 
(2009). Prevalence and Clinical Significance of Medication Discrepancies at 
Pediatric Hospital Admission. Academic Pediatrics, 9(5). 
https://doi.org/10.1016/j.acap.2009.04.007 
Cohen, E., Kuo, D. Z., Agrawal, R., Berry, J. G., Bhagat, S. K. M., Simon, T. D., & 
Srivastava, R. (2011). Children With Medical Complexity: An Emerging Population 
for Clinical and Research Initiatives. PEDIATRICS, 127(3), 529–538. 
https://doi.org/10.1542/peds.2010-0910 
Cornish, P. L., Knowles, S. R., Marchesano, R., Tam, V., Shadowitz, S., Juurlink, D. N., 
& Etchells, E. E. (2005). Unintended medication discrepanies at the time of hospital 
admission. Arch Intern Med, 165, 424–429. 
 40 
Dean, B., Schachter, M., Vincent, C., & Barber, N. (2002). Prescribing errors in hospital 
inpatients: their incidence and clinical significance. Quality & Safety in Health 
Care, 11(4), 340–344. https://doi.org/10.1136/QHC.11.4.340 
DeFrances, C. J., & Hall, M. J. (2007). 2005 National Hospital Discharge Survey. 
Advance Data, (385), 1–19. 
Fernandes, O., & Shojania, K. (2012). Medication Reconciliation in the Hospital: What, 
Why, Where, When, Who and How? Healthcare Quarterly, 15(sp), 42–49. 
https://doi.org/10.12927/hcq.2012.22842 
Feudtner, C., Dai, D., Hexem, K. R., Luan, X., & Metjian, T. A. (2012). Prevalence of 
polypharmacy exposure among hospitalized children in the United States. Archives 
of Pediatrics and Adolescent Medicine, 166(1), 9–16. 
https://doi.org/10.1001/archpediatrics.2011.161 
Feudtner, C., Feinstein, J. A., Zhong, W., Hall, M., & Dai, D. (2014). Pediatric complex 
chronic conditions classification system version 2: updated for ICD-10 and complex 
medical technology dependence and transplantation. BMC Pediatrics, 14(1), 199. 
https://doi.org/10.1186/1471-2431-14-199 
Feudtner, C., Villareale, N. L., Morray, B., Sharp, V., Hays, R. M., & Neff, J. M. (2005). 
Technology-dependency among patients discharged from a children’s hospital: a 
retrospective cohort study. BMC Pediatrics, 5(1), 8. https://doi.org/10.1186/1471-
2431-5-8 
Ghaleb, M. A., Barber, N., Franklin, B. D., Yeung, V. W., Khaki, Z. F., & Wong, I. C. 
(2006). Systematic Review of Medication Errors in Pediatric Patients. Ann 
Pharrnacother, 40, 1766–1776. https://doi.org/10.1345/aph.1 
Gordon, J. B., Colby, H. H., Bartelt, T., Jablonski, D., Krauthoefer, M. L., & Havens, P. 
(2007). A Tertiary Care–Primary Care Partnership Model for Medically Complex 
and Fragile Children and Youth With Special Health Care Needs. Archives of 
Pediatrics & Adolescent Medicine, 161(10), 937. 
https://doi.org/10.1001/archpedi.161.10.937 
 
 41 
Granger, B. B., & Bosworth, H. B. (2011). Medication adherence: emerging use of 
technology. Current Opinion in Cardiology, 26(4), 279–287. 
https://doi.org/10.1097/HCO.0b013e328347c150 
Hayakawa, M., Uchimura, Y., Omae, K., Waki, K., Fujita, H., & Ohe, K. (2013). A 
Smartphone-based Medication Self-management System with Real-time Medication 
Monitoring. Applied Clinical Informatics, 4(1), 37–52. https://doi.org/10.4338/ACI-
2012-10-RA-0045 
Jack, B. W., Chetty, V. K., Anthony, D., Greenwald, J. L., & Sanchez, G. M. (2009). A 
Reengineered Hospital Discharge Program to Decrease Rehospitalization: A 
randomized trial. Annals of Internal Medicine, 150(25), 178–187. 
Joint Commission. (n.d.). National Patient Safety Goals. Retrieved March 22, 2018, from 
https://www.jointcommission.org/standards_information/npsgs.aspx 
Jyrkkä, J., Enlund, H., Korhonen, M. J., Sulkava, R., & Hartikainen, S. (2009). Patterns 
of Drug Use and Factors Associated with Polypharmacy and Excessive 
Polypharmacy in Elderly Persons. Drugs & Aging, 26(6), 493–503. 
https://doi.org/10.2165/00002512-200926060-00006 
Karnon, J., Campbell, F., & Czoski-Murray, C. (2009). Model-based cost-effectiveness 
analysis of interventions aimed at preventing medication error at hospital admission 
(medicines reconciliation). Journal of Evaluation in Clinical Practice, 15(2), 299–
306. https://doi.org/10.1111/j.1365-2753.2008.01000.x 
Kaushal, R., Bates, D. W., Landrigan, C., McKenna, K. J., Clapp, M. D., Federico, F., & 
Goldmann, D. A. (2001). Medication Errors and Adverse Drug Events in Pediatric 
Inpatients. JAMA, 285(16), 2114. https://doi.org/10.1001/jama.285.16.2114 
Koehler, B. E., Richter, K. M., Youngblood, L., Cohen, B. A., Prengler, I. D., Cheng, D., 
… Koehler, B. E. (2009). Reduction of 30-day postdischarge hospital readmission or 
emergency department (ED) visit rates in high-risk elderly medical patients through 
delivery of a targeted care bundle. Journal of Hospital Medicine, 4(4), 211–218. 
https://doi.org/10.1002/jhm.427 
 
 42 
Kohn, L. T., Corrigan, J. M., & Donaldson, M. S. (2000). To err is human: building a 
safer health system. Annales francaises d’anesthesie et de reanimation (Vol. 21). 
https://doi.org/10.1017/S095026880100509X 
Kripalani, S., Jackson, A. T., Schnipper, J. L., & Coleman, E. A. (2007). Promoting 
effective transitions of care at hospital discharge: A review of key issues for 
hospitalists. Journal of Hospital Medicine, 2(5), 314–323. 
https://doi.org/10.1002/jhm.228 
Kripalani, S., Roumie, C. L., Dalal, A. K., Cawthon, C., Businger, A., Eden, S. K., … 
Group,  for the P.-C. (Pharmacist I. for L. L. in C. D. S. (2012). Effect of a 
Pharmacist Intervention on Clinically Important Medication Errors After Hospital 
Discharge. Annals of Internal Medicine, 157(1), 1. https://doi.org/10.7326/0003-
4819-157-1-201207030-00003 
Kwan, J. L., Lo, L., Sampson, M., & Shojania, K. G. (2013). Medication Reconciliation 
During Transitions of Care as a Patient Safety Strategy. Annals of Internal Medicine, 
158, 397. https://doi.org/10.7326/0003-4819-158-5-201303051-00006 
Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H. J., Gallivan, T., … 
Laffel, G. (1995). Systems analysis of adverse drug events. ADE Prevention Study 
Group. JAMA, 274(1), 35–43. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/7791256 
Lesar, T. S., Mitchell, A., & Sommo, P. (2006). Medication Safety in Critically Ill 
Children. Clinical Pediatric Emergency Medicine, 7(4), 215–225. 
https://doi.org/10.1016/j.cpem.2006.08.009 
Lewis, P. J., Dornan, T., Taylor, D., Tully, M. P., Wass, V., & Ashcroft, D. M. (2009). 
Prevalence, incidence and nature of prescribing errors in hospital inpatients: a 
systematic review. Drug Safety, 32(5), 379–389. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/19419233 
Lin, H.-Y., Liao, C.-C., Cheng, S.-H., Wang, P.-C., & Hsueh, Y.-S. (2008). Association 
of potentially inappropriate medication use with adverse outcomes in ambulatory 
elderly patients with chronic diseases: experience in a Taiwanese medical setting. 
Drugs & Aging, 25(1), 49–59. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/18184029 
 43 
Maaskant, J. M., Vermeulen, H., Apampa, B., Fernando, B., Ghaleb, M. a., Neubert, A., 
… Soe, A. (2015). Interventions for reducing medication errors in children in 
hospital. The Cochrane Database of Systematic Reviews, 3(3), CD006208. 
https://doi.org/10.1002/14651858.CD006208.pub3 
Medication Errors | AHRQ Patient Safety Network. (2017). Retrieved March 2, 2018, 
from https://psnet.ahrq.gov/primers/primer/23/medication-errors 
Meguerditchian, A. N., Krotneva, S., Reidel, K., Huang, A., & Tamblyn, R. (2013). 
Medication reconciliation at admission and discharge: a time and motion study. 
BMC Health Services Research, 13(1), 485. https://doi.org/10.1186/1472-6963-13-
485 
Metsälä, E., & Vaherkoski, U. (2014). Medication errors in elderly acute care - a 
systematic review. Scandinavian Journal of Caring Sciences, 28(1), 12–28. 
https://doi.org/10.1111/scs.12034 
Miller, M. R., Elixhauser, A., & Zhan, C. (2003). Patient safety events during pediatric 
hospitalizations. Pediatrics, 111(6 Pt 1), 1358–1366. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12777553 
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., 
… Haynes, R. B. (2008). Interventions for enhancing medication adherence. In R. 
Nieuwlaat (Ed.), Cochrane Database of Systematic Reviews (p. CD000011). 
Chichester, UK: John Wiley & Sons, Ltd. 
https://doi.org/10.1002/14651858.CD000011.pub3 
Organization, W. H., & others. (2008). World Alliance for Patient Safety Progress Report 
2006-2007. 
Palfrey, J. S., Walker, D. K., Haynie, M., Singer, J. D., Porter, S., Bushey, B., & 
Cooperman, P. (1991). Technology’s children: report of a statewide census of 
children dependent on medical supports. Pediatrics, 87(5), 611–618. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/2020504 
Pham, H. H., Schrag, D., O’Malley, A. S., Wu, B., & Bach, P. B. (2007). Care Patterns in 
Medicare and Their Implications for Pay for Performance. New England Journal of 
Medicine, 356(11), 1130–1139. https://doi.org/10.1056/NEJMsa063979 
 44 
Pippins, J. R., Gandhi, T. K., Hamann, C., Ndumele, C. D., Labonville, S. A., 
Diedrichsen, E. K., … Schnipper, J. L. (2008). Classifying and Predicting Errors of 
Inpatient Medication Reconciliation. Journal of General Internal Medicine, 23(9), 
1414–1422. https://doi.org/10.1007/s11606-008-0687-9 
Steurbaut, S., Leemans, L., Leysen, T., De Baere, E., Cornu, P., Mets, T., & Dupont, A. 
G. (2010). Medication history reconciliation by clinical pharmacists in elderly 
inpatients admitted from home or a nursing home. Annals of Pharmacotherapy, 
44(10), 1596–1603. https://doi.org/10.1345/aph.1P192 
Stone, B. L., Boehme, S., Mundorff, M. B., Maloney, C. G., & Srivastava, R. (2010). 
Hospital admission medication reconciliation in medically complex children: An 
observational study. Archives of Disease in Childhood, 95(4), 250–255. 
https://doi.org/10.1136/adc.2009.167528 
Sullivan, C., Gleason, K. M., Rooney, D., Groszek, J. M., & Barnard, C. (2005). 
Medication Reconciliation in the Acute Care Setting: Opportunity and Challenge for 
Nursing. Journal of Nursing Care Quality, 20(2), 95–98. Retrieved from 
https://insights.ovid.com/pubmed?pmid=15839287 
Tam, V. C., Knowles, S. R., Cornish, P. L., Fine, N., Marchesano, R., & Etchells, E. E. 
(2005). Frequency, type and clinical importance of medication history errors at 
admission to hospital: a systematic review. CMAJ : Canadian Medical Association 
Journal = Journal de l’Association Medicale Canadienne, 173(5), 510–515. 
https://doi.org/10.1503/cmaj.045311 
van Dyck, P. C., Kogan, M. D., McPherson, M. G., Weissman, G. R., & Newacheck, P. 
W. (2004). Prevalence and Characteristics of Children With Special Health Care 
Needs. Archives of Pediatrics & Adolescent Medicine, 158(9), 884. 
https://doi.org/10.1001/archpedi.158.9.884 
van Sluisveld, N., Zegers, M., Natsch, S., & Wollersheim, H. (2012). Medication 
reconciliation at hospital admission and discharge: insufficient knowledge, unclear 
task reallocation and lack of collaboration as major barriers to medication safety. 
BMC Health Services Research, 12(1), 170. https://doi.org/10.1186/1472-6963-12-
170 
 
 45 
van Walraven, C., Taljaard, M., Etchells, E., Bell, C. M., Stiell, I. G., Zarnke, K., & 
Forster, A. J. (2010). The independent association of provider and information 
continuity on outcomes after hospital discharge: Implications for hospitalists. 
Journal of Hospital Medicine, 5(7), 398–405. https://doi.org/10.1002/jhm.716 
Vervloet, M., van Dijk, L., Santen-Reestman, J., van Vlijmen, B., Bouvy, M. L., & de 
Bakker, D. H. (2011). Improving medication adherence in diabetes type 2 patients 
through Real Time Medication Monitoring: a Randomised Controlled Trial to 
evaluate the effect of monitoring patients’ medication use combined with short 
message service (SMS) reminders. BMC Health Services Research, 11(1), 5. 
https://doi.org/10.1186/1472-6963-11-5 
Vira, T., Colquhoun, M., & Etchells, E. (2006). Reconcilable differences: correcting 
medication errors at hospital admission and discharge. Quality & Safety in Health 
Care, 15(2), 122–126. https://doi.org/10.1136/qshc.2005.015347 
Wakefield, D. S., Wakefield, B. J., Uden-Holman, T., Borders, T., Blegen, M., & 
Vaughn, T. (1999). Understanding Why Medication Administration Errors May Not 
Be Reported. American Journal of Medical Quality, 14(2), 81–88. 
https://doi.org/10.1177/106286069901400203 
Wong, I. C. K., Ghaleb, M. A., Franklin, B. D., & Barber, N. (2004). Incidence and 
nature of dosing errors in paediatric medications: a systematic review. Drug Safety, 
27(9), 661–670. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15230647 
  
 46 
CURRICULUM VITAE 
 
  
 47 
                  
                    
           
 48 
  
 
 49 
  
